From: TKTL1 expression in human malign and benign cell lines
Cell line | Antibody | |||||
---|---|---|---|---|---|---|
JFC12T10 | 1C10 | Sigma Prestige | ||||
Most prominent signal (kDa) | 2nd prominent signal (kDa) | Further signals (kDa) | Most prominent signal (kDa) | Further signals (kDa)* | Most prominent signal (kDa) | |
Fibroblasts | - | - | 27/40/55/60 | - | - | - |
HCT116 | 27 | - | multiple | - | 37/55/65 | - |
HEK 293 -control | 27 | 37 | 45/55/65/70 | - | - | - |
HEK 293-TKTL1 | 65 | 27/37 | multiple | 65 | - | 65 |
HeLa | 27 | - | multiple | - | 37/40/47/65 | - |
HepG2 | 27 | 37/45 | multiple | - | - | - |
HT-29 | 27 | - | - | - | - | - |
HUVEC | 27 | 37/40/45/50 | multiple | - | - | - |
JAR | 27 | 37 | multiple | - | 37/55 | - |
JEG | 27 | 40 | multiple | - | - | - |
23132/87 | 27 | 37/45 | multiple | - | - | - |
MCF-7 | 27 | - | multiple | - | 37/40/50/70 | - |
MDA-MB 231 | 27 | 40 | multiple | - | 37/40 | - |
Mel2A | 27 | 45/40 | multiple | - | 45/55/70 | - |
OVCAR | 27 | 42 | multiple | - | 37/40/50/90 | - |
PA1 | 27 | 37 | multiple | - | 55 | - |
SiHa | 27 | 42 | multiple | - | - | - |
SKOV3 | 27 | 37 | multiple | - | 37740/55 | - |
U251 | 27 | 40/45/55 | multiple | - | 45 | - |
U87 | 27 | 55 | multiple | - | 45 | - |
WiDr | 27 | 42 | multiple | - | - | - |
WS1 | - | - | 40/55/70* | 40/55/65 | - |